Altoneuroscience.com

Alto Neuroscience

WebLeading Clinical-Stage Pipeline. With multiple medicines in our pipeline for mental health conditions, including depression and post-traumatic stress disorder (PTSD), we are …

Actived: 3 days ago

URL: https://www.altoneuroscience.com/

Precision Psychiatry 101: Domains

WebLearn about the rapidly evolving field of precision psychiatry, which tailors mental health treatments to an individual's unique brain biology. Alto Neuroscience has identified and …

Category:  Health Go Health

Precision Psychiatry 101: Science

WebPrecision Psychiatry 101 is a four-part series highlighting pillars of Alto’s approach to psychiatric drug development that matches the right patient with the right drug. Advances …

Category:  Health Go Health

Jan 10, 2023 Press Release

WebLOS ALTOS, Calif., January 10, 2023 – Alto Neuroscience Inc. today reported results from its Phase 2a study of ALTO-100, demonstrating clear evidence of efficacy and favorable …

Category:  Health Go Health

Precision Psychiatry 101: Innovation

WebPrecision Psychiatry 101 is a four-part series highlighting pillars of Alto’s approach to psychiatric drug development that matches the right patient with the right drug. The …

Category:  Health Go Health

Alto Neuroscience, Inc.

Web– Treatment with ALTO-300 led to a significantly greater improvement in depression symptoms in a biomarker-characterized patient population – ‍ – A machine …

Category:  Health Go Health

Nov 11, 2021 Press Release

WebLOS ALTOS,Calif., Nov. 11, 2021 – Alto Neuroscience today announced the publication of the first ever, most comprehensive data-driven neurological mapping of the mind in the …

Category:  Health Go Health

Nov 15, 2022 Press Release

Web– Industry awards recognize the company for overall biopharma innovation of the year and as a best place to work in life sciences – LOS ALTOS, Calif., November 15, …

Category:  Health Go Health

Sep 26, 2023 Press ReleaseAlto Neuroscience Announces Positive …

WebLOS ALTOS, Calif., September 26, 2023 – Alto Neuroscience Inc. today reported results from the post-traumatic stress disorder (PTSD) cohort in its Phase 2a …

Category:  Health Go Health

Alto Neuroscience Announces Data from Presentations at the …

WebLOS ALTOS, Calif., December 7, 2023 – Alto Neuroscience, Inc. today announced details from three presentations on clinical development programs presented at the 62 nd …

Category:  Health Go Health

2023: When AI & Clinical Trial Innovations Converge

WebAt BIO 2023, Alto founder and CEO Amit Etkin, MD, PhD, had an opportunity to connect with fellow industry leaders to discuss how data-driven approaches and patient-centric …

Category:  Health Go Health

Oct 25, 2022 Press Release

WebAlto Neuroscience Announces $35 Million Series B Financing. October 25, 2022. Download PDF. – Co-led by two new investors, Lightswitch Capital and partners of …

Category:  Health Go Health

Dec 14, 2022 Press Release

WebLOS ALTOS, Calif., December 14, 2022 – Alto Neuroscience today announced top-line results from a Phase 1 human brain mechanism study of a series of novel combination …

Category:  Health Go Health

Alto Neuroscience Closes $45 Million in Oversubscribed Series C …

WebLOS ALTOS, Calif., November 21, 2023 – Alto Neuroscience, Inc. today announced an oversubscribed $45 million Series C financing. The round was led by InVivium Capital, …

Category:  Health Go Health

Oct 14, 2021 Press Release

WebAlto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing. October 14, 2021. Download PDF. -Advancing 11 clinical-stage …

Category:  Health Go Health

Dec 04, 2023 Press ReleasePress Release: Alto Neuroscience …

WebLOS ALTOS, Calif., December 4, 2023 – Alto Neuroscience, Inc. today announced positive results from its Phase 2a study of ALTO-300 at the 62 nd Annual Meeting of the …

Category:  Health Go Health